Ensign Peak Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Hold |
|
|||||
|
2025
Q1 | $935K | Hold |
|
|||||
|
2024
Q4 | $989K | Hold |
|
|||||
|
2024
Q3 | $925K | Hold |
|
|||||
|
2024
Q2 | $725K | Hold |
|
|||||
|
2024
Q1 | $765K | Sell |
|
|||||
|
2023
Q4 | $853K | Hold |
|
|||||
|
2023
Q3 | $425K | Buy |
|
|||||
|
2023
Q2 | $267K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.16M | Buy |
|
|||||
|
2022
Q3 | $274K | Sell |
|
|||||
|
2022
Q2 | $122K | Buy |
|
|||||
|
2022
Q1 | $59K | Hold |
|
|||||
|
2021
Q4 | $51K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $801K | Hold |
|
|||||
|
2021
Q1 | $870K | Buy |
|
|||||
|
2020
Q4 | $629K | Hold |
|
|||||
|
2020
Q3 | $459K | Buy |
|